Increasing Dose Intensity Of Chemotherapy In Osteosarcoma Offers No Benefit Study Finds

... A dose-intensive regimen of the chemotherapy drugs cisplatin and doxorubicin offered no clinical benefit over standard doses of the chemotherapy drugs in patients with a bone cancer called osteosarcoma, according to results from a randomized trial in the January 17 issue of the Journal of the National Cancer Institute. [click link for full article] ...